1. Home
  2. EPSN vs NKTX Comparison

EPSN vs NKTX Comparison

Compare EPSN & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPSN
  • NKTX
  • Stock Information
  • Founded
  • EPSN 2005
  • NKTX 2015
  • Country
  • EPSN Canada
  • NKTX United States
  • Employees
  • EPSN N/A
  • NKTX N/A
  • Industry
  • EPSN Oil & Gas Production
  • NKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • EPSN Energy
  • NKTX Health Care
  • Exchange
  • EPSN Nasdaq
  • NKTX Nasdaq
  • Market Cap
  • EPSN 153.4M
  • NKTX 170.8M
  • IPO Year
  • EPSN N/A
  • NKTX 2020
  • Fundamental
  • Price
  • EPSN $6.48
  • NKTX $1.85
  • Analyst Decision
  • EPSN Strong Buy
  • NKTX Strong Buy
  • Analyst Count
  • EPSN 1
  • NKTX 6
  • Target Price
  • EPSN $7.00
  • NKTX $15.00
  • AVG Volume (30 Days)
  • EPSN 52.0K
  • NKTX 2.5M
  • Earning Date
  • EPSN 05-07-2025
  • NKTX 05-08-2025
  • Dividend Yield
  • EPSN 3.81%
  • NKTX N/A
  • EPS Growth
  • EPSN N/A
  • NKTX N/A
  • EPS
  • EPSN 0.09
  • NKTX N/A
  • Revenue
  • EPSN $31,522,775.00
  • NKTX N/A
  • Revenue This Year
  • EPSN $41.35
  • NKTX N/A
  • Revenue Next Year
  • EPSN N/A
  • NKTX N/A
  • P/E Ratio
  • EPSN $74.63
  • NKTX N/A
  • Revenue Growth
  • EPSN 2.58
  • NKTX N/A
  • 52 Week Low
  • EPSN $4.95
  • NKTX $1.31
  • 52 Week High
  • EPSN $7.32
  • NKTX $8.33
  • Technical
  • Relative Strength Index (RSI)
  • EPSN 47.11
  • NKTX 56.56
  • Support Level
  • EPSN $6.06
  • NKTX $1.67
  • Resistance Level
  • EPSN $6.81
  • NKTX $1.84
  • Average True Range (ATR)
  • EPSN 0.37
  • NKTX 0.14
  • MACD
  • EPSN -0.03
  • NKTX 0.03
  • Stochastic Oscillator
  • EPSN 36.36
  • NKTX 75.44

About EPSN Epsilon Energy Ltd. Common Share

Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.

About NKTX Nkarta Inc.

Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.

Share on Social Networks: